Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis.
Hyoungyoung KimSoo Kyung ChoSeongmi ChoiSeul Gi ImSun-Young JungEun Jin JangYoon-Kyoung SungPublished in: Therapeutic advances in musculoskeletal disease (2021)
Annual RA-related direct medical costs and RA-related healthcare utilization per patient are higher in patients with SPRA than those with SNRA.